Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

Hepatitis C virus clearance is expected in more than 95% of patients treated with direct-acting antivirals (DAAs). However, an extensive debate about the impact of DAAs on the development of hepatocellular carcinoma (HCC) is currently ongoing. This review aimed to explore currently available evidenc...

Full description

Saved in:
Bibliographic Details
Published in:J Adv Res
Main Authors: El Kassas, Mohamed, Elbaz, Tamer, Salaheldin, Mohamed, Abdelsalam, Lobna, Kaseb, Ahmed, Esmat, Gamal
Format: Artigo
Language:Inglês
Published: Elsevier 2019
Subjects:
Mini Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526204/
https://ncbi.nlm.nih.gov/pubmed/31193326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jare.2019.03.001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items